Ethnic differences in brain-derived neurotrophic factor Val66Met polymorphism in Croatian and Korean healthy participants
- PMID: 19260143
- PMCID: PMC2657559
- DOI: 10.3325/cmj.2009.50.43
Ethnic differences in brain-derived neurotrophic factor Val66Met polymorphism in Croatian and Korean healthy participants
Abstract
Aim: To compare the frequency of alleles and genotypes in brain-derived neurotrophic factor (BDNF) val66met polymorphism in ethnically homogenous Caucasian (from Croatia) and ethnically homogenous Asian (from South Korea) healthy participants, as inter-population differences in BDNF val66met may be responsible for the divergent findings in genetic and association studies.
Methods: BDNF val66met was genotyped in 800 (556 Croatian and 244 Korean) healthy participants. Frequencies of alleles and genotypes were evaluated using a chi(2) test.
Results: The frequencies for genotypes (chi(2)2=114.69; P<0.001) and alleles (chi(2)1=120.07; P<0.001) between Korean and Croatian individuals differed significantly, due to significantly lower (46.3% and 19.5%, P<0.001) frequency of "Met" allele and significantly higher (53.7% and 80.5%, P<0.001) frequency of "Val" allele in Croatian than in Korean participants.
Conclusion: The study found significant ethnic differences in BDNF val66met polymorphism. The most frequent genotype among Korean participants was "Met/Val" and they had similar distribution of "Met" and "Val" alleles. In contrast, the most frequent genotype among Caucasian participants was "Val/Val" and they had different distribution of "Met" and "Val" alleles. These ethnic differences require matching participants for ethnicity in pharmacogenetic studies and in the studies investigating genetic variations in neuropsychiatric disorders.
Similar articles
-
Association between brain-derived neurotrophic factor Val66Met and obesity in children and adolescents.Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jan 10;36(1):136-40. doi: 10.1016/j.pnpbp.2011.08.003. Epub 2011 Aug 7. Prog Neuropsychopharmacol Biol Psychiatry. 2012. PMID: 21851847
-
Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):356-62. doi: 10.1016/j.pnpbp.2010.10.020. Epub 2010 Oct 31. Prog Neuropsychopharmacol Biol Psychiatry. 2011. PMID: 21044653
-
Brain-derived neurotrophic factor Val66Met polymorphism and alcohol-related phenotypes.Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jan 10;40:193-8. doi: 10.1016/j.pnpbp.2012.09.005. Epub 2012 Sep 27. Prog Neuropsychopharmacol Biol Psychiatry. 2013. PMID: 23023098
-
Impact of brain-derived neurotrophic factor genetic polymorphism on cognition: A systematic review.Brain Behav. 2018 Jul;8(7):e01009. doi: 10.1002/brb3.1009. Epub 2018 Jun 1. Brain Behav. 2018. PMID: 29858545 Free PMC article.
-
The impact of BDNF Val66Met polymorphism on cognition in Bipolar Disorder: A review: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.J Affect Disord. 2019 Jan 15;243:552-558. doi: 10.1016/j.jad.2018.07.054. Epub 2018 Jul 24. J Affect Disord. 2019. PMID: 30078664 Review.
Cited by
-
Effects of BDNF Val66Met Polymorphism on White Matter Microalterations of the Corpus Callosum in Patients with Panic Disorder in Korean Populations.Psychiatry Investig. 2020 Oct;17(10):967-975. doi: 10.30773/pi.2020.0186. Epub 2020 Oct 7. Psychiatry Investig. 2020. PMID: 33017888 Free PMC article.
-
Brain-Derived Neurotrophic Factor Gene Polymorphism, Craving, and Stress Among Alcohol-Dependent Patients: A Preliminary Cross-sectional Study from India.Addict Health. 2025 Jan;17:1593. doi: 10.34172/ahj.1593. Epub 2025 Mar 15. Addict Health. 2025. PMID: 40502460 Free PMC article.
-
Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients.Psychopharmacology (Berl). 2014 Sep;231(18):3757-64. doi: 10.1007/s00213-014-3515-4. Epub 2014 Mar 5. Psychopharmacology (Berl). 2014. PMID: 24595507
-
A sexually dimorphic pre-stressed translational signature in CA3 pyramidal neurons of BDNF Val66Met mice.Nat Commun. 2017 Oct 9;8(1):808. doi: 10.1038/s41467-017-01014-4. Nat Commun. 2017. PMID: 28993643 Free PMC article.
-
Moderating Effects of BDNF Genetic Variants and Smoking on Cognition in PTSD Veterans.Biomolecules. 2021 Apr 26;11(5):641. doi: 10.3390/biom11050641. Biomolecules. 2021. PMID: 33926045 Free PMC article.
References
-
- Gratacos M, Gonzalez JR, Mercader JM, de Cid R, Urretavizcaya M, Estivill X. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol Psychiatry. 2007;61:911–22. doi: 10.1016/j.biopsych.2006.08.025. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous